Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solrikitug in Adult Participants With Asthma
NCT06496607Phase 2Completed
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of solrikitug in asthma. Started Jul 2024; status: completed.
02
Drugs
solrikitug
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06496607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06496607.